FDA Inspection 592681 — Numare Spectralab, Inc.
The FDA completed an inspection of Numare Spectralab, Inc. on June 26, 2009 in Kintnersville, PA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- June 26, 2009
- Fiscal Year
- 2009
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Kintnersville, PA (United States)